(Q37124961)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18380812%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

review article

1 reference

title

Economic evaluation of prostate cancer screening with prostate-specific antigen (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18380812%20AND%20SRC:MED&resulttype=core&format=json

prostate cancer screening

5 January 2020

main subject

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18380812%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Tomoaki Imamura

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18380812%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

publication date

1 April 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18380812%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Urology

5 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18380812%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18380812%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18380812%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

285-288

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18380812%20AND%20SRC:MED&resulttype=core&format=json

Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party

5 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02013.X

An evaluation of prostate-specific antigen as a screening test for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02013.X

Prostate cancer screening: what we know and what we need to know.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02013.X

Evaluation of prostatic specific antigen and digital rectal examination as screening tests for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02013.X

Cost-benefit analysis of total, free/total, and complexed prostate-specific antigen for prostate cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02013.X

Prostate cancer screening strategies with re-screening interval determined by individual baseline prostate-specific antigen values are cost-effective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02013.X

Costs and effects of prostate cancer screening in Sweden--a 15-year follow-up of a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02013.X

Early detection of prostate cancer. Part II: Estimating the risks, benefits, and costs. American College of Physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02013.X

Decision analysis and Markov modeling in urology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02013.X

Benefit evaluation of mass screening for prostate cancer: willingness-to-pay measurement using contingent valuation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02013.X

Women's anxieties caused by false positives in mammography screening: a contingent valuation survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02013.X

The contingent valuation method in health care

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02013.X

Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02013.X

Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02013.X

Baseline health-related quality of life in the management of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02013.X

Screening for prostate cancer. A decision analytic view

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2008.02013.X